Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress.

[1]  G. Chrousos,et al.  Neuroendocrinology of stress. , 2001, Endocrinology and metabolism clinics of North America.

[2]  G. Chrousos.  The role of stress and the hypothalamic–pituitary–adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes , 2000, International Journal of Obesity.

[3]  G. Chrousos,et al.  Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[4]  D. Torpy,et al.  Stress, Corticotropin‐Releasing Hormone, Glucocorticoids, and the Immune/Inflammatory Response: Acute and Chronic Effects a , 1999, Annals of the New York Academy of Sciences.

[5]  G. Chrousos,et al.  The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequences. , 1999, Proceedings of the Association of American Physicians.

[6]  G. Chrousos,et al.  Interactions between the Hypothalamic-Pituitary-Adrenal Axis and the Female Reproductive System: Clinical Implications , 1998, Annals of Internal Medicine.

[7]  G. Chrousos,et al.  A healthy body in a healthy mind--and vice versa--the damaging power of "uncontrollable" stress. , 1998, The Journal of clinical endocrinology and metabolism.

[8]  G. Chrousos,et al.  Stressors, Stress, and Neuroendocrine Integration of the Adaptive Response: The 1997 Hans Selye Memorial Lecture , 1998, Annals of the New York Academy of Sciences.

[9]  G. Koob,et al.  Corticotropin Releasing Factor Receptor 1–Deficient Mice Display Decreased Anxiety, Impaired Stress Response, and Aberrant Neuroendocrine Development , 1998, Neuron.

[10]  D. Papanicolaou,et al.  Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. , 1997, The Journal of clinical endocrinology and metabolism.

[11]  D. Papanicolaou,et al.  Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure. , 1997, Neuroendocrinology.

[12]  A. Turnbull,et al.  Corticotropin-Releasing Factor (CRF) and Endocrine Responses to Stress: CRF Receptors, Binding Protein, and Related Peptides , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[13]  G. Chrousos,et al.  The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. , 1995, The New England journal of medicine.

[14]  J. Cidlowski,et al.  Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors , 1995, Molecular and cellular biology.

[15]  J. Licinio,et al.  Localization of corticotropin-releasing hormone (CRH) receptor mRNA in adult rat brain by in situ hybridization histochemistry. , 1994, Endocrinology.

[16]  C. Tsigos,et al.  Physiology of the hypothalamic-pituitary-adrenal axis in health and dysregulation in psychiatric and autoimmune disorders. , 1994, Endocrinology and metabolism clinics of North America.

[17]  E. Benarroch,et al.  Neuropeptides in the sympathetic system: Presence, plasticity, modulation, and implications , 1994, Annals of neurology.

[18]  G. Chrousos,et al.  Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimophism of the stress response and immune/inflammatory reaction. , 1993, The Journal of clinical investigation.

[19]  M. Hotta,et al.  Psychological stress increases arousal through brain corticotropin-releasing hormone without significant increase in adrenocorticotropin and catecholamine secretion , 1993, Brain Research.

[20]  K. Spyer,et al.  Essential organization of the sympathetic nervous system. , 1993, Bailliere's clinical endocrinology and metabolism.

[21]  R. Young,et al.  Diabetic neuropathy is associated with increased activity of the hypothalamic-pituitary-adrenal axis. , 1993, The Journal of clinical endocrinology and metabolism.

[22]  T. Hökfelt,et al.  The chemical neuroanatomy of sympathetic ganglia. , 1993, Annual review of neuroscience.

[23]  D. Toft,et al.  Steroid receptors and their associated proteins. , 1993, Molecular endocrinology.

[24]  G. Chrousos.  Regulation and dysregulation of the hypothalamic-pituitary-adrenal axis. The corticotropin-releasing hormone perspective. , 1992, Endocrinology and metabolism clinics of North America.

[25]  G. Kingsley,et al.  Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. , 1992, Arthritis and rheumatism.

[26]  G. Chrousos,et al.  The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. , 1992, JAMA.

[27]  S. Rivest,et al.  Effect of stress on the activity of the hypothalamic-pituitary-gonadal axis: peripheral and central mechanisms. , 1991, Biology of reproduction.

[28]  E. D. Kloet,et al.  Brain corticosteroid receptor balance and homeostatic control , 1991 .

[29]  C. Nemeroff,et al.  Stress, Neuropeptides, and Systemic Disease , 1991 .

[30]  G. Benker,et al.  Tsh Secretion In Cushing's Syndrome: Relation To Glucocorticoid Excess, Diabetes, Goitre, And The ‘Sick Euthyroid Syndrome’ , 1990, Clinical endocrinology.

[31]  D. London,et al.  PATTERNS OF ACTH AND CORTISOL PULSATILITY OVER TWENTY‐FOUR HOURS IN NORMAL MALES AND FEMALES , 1990, Clinical endocrinology.

[32]  B. Burguera,et al.  Acute administration of corticoids: a new and peculiar stimulus of growth hormone secretion in man. , 1990, The Journal of clinical endocrinology and metabolism.

[33]  J. Hinson.  Paracrine control of adrenocortical function: a new role for the medulla? , 1990, The Journal of endocrinology.

[34]  W. Pratt.  Glucocorticoid receptor structure and the initial events in signal transduction. , 1990, Progress in clinical and biological research.

[35]  B. Burguera,et al.  Dual and selective actions of glucocorticoids upon basal and stimulated growth hormone release in man. , 1990, Neuroendocrinology.

[36]  J W Funder,et al.  Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia. , 1989, Neuroendocrinology.

[37]  R. Roth,et al.  Stress and the Mesocorticolimbic Dopamine Systems a , 1988, Annals of the New York Academy of Sciences.

[38]  G. Chrousos,et al.  Multiple feedback regulatory loops upon rat hypothalamic corticotropin-releasing hormone secretion. Potential clinical implications. , 1988, The Journal of clinical investigation.

[39]  F. Goodwin,et al.  Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2) , 1988, The New England journal of medicine.

[40]  Phillips Mi.  Functions of Angiotensin in the Central Nervous System , 1987 .

[41]  A. Herz,et al.  Stimulation of hypothalamic β-endorphin and dynorphin release by corticotropin-releasing factor (in vitro) , 1986, Brain Research.

[42]  K. Catt,et al.  Magnocellular axons in passage through the median eminence release vasopressin , 1986, Nature.

[43]  S. Lamberts,et al.  Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man. , 1984, The Journal of clinical endocrinology and metabolism.

[44]  J. Ottenweller,et al.  Adrenal innervation may be an extrapituitary mechanism able to regulate adrenocortical rhythmicity in rats. , 1982, Endocrinology.

[45]  W. Vale,et al.  Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin , 1981 .

[46]  H. Selye.  A Syndrome produced by Diverse Nocuous Agents , 1936, Nature.